Auger Electron Therapy Enhanced by Heat-Triggered Release of I-125-Labeled DNA-Targeted Compounds within the Tumor Microenvironment
Open Access
- 24 July 2026
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 23 (9) , 4681-4689
Abstract
In Auger electron therapy, the effective delivery of Auger electron-emitting radionuclides to the nuclei of cancer cells is essential for achieving high therapeutic efficacy. In this study, we developed a novel strategy that combined thermosensitive liposomes (TSLs) encapsulating 125I-labeled DNA-targeted compounds. This approach enabled enhanced tumor accumulation via TSL-mediated delivery and efficient nuclear translocation of radioactivity by releasing an 125I-labeled doxorubicin derivative ([125I]I-DOX) within the tumor microenvironment. [125I]I-DOX exhibited high cellular and nuclear uptake, producing potent cytotoxicity through Auger electrons emitted from 125I. [125I]I-DOX-loaded TSLs efficiently released [125I]I-DOX at 43 °C, enhancing its cellular uptake by Colon-26 cells. Tumor accumulation of radioactivity in the heating group was much higher than in the nonheating group, and the accumulation was maintained for up to 48 h postinjection. Intravenous injection of [125I]I-DOX-loaded TSLs (5.0 MBq) and localized tumor heating significantly inhibited tumor growth without body weight loss. The combination of [125I]I-DOX-loaded TSLs and hyperthermia represents a promising strategy for Auger electron therapy targeting the nuclei of cancer cells.Keywords
Funding Information
- Society of Iodine Science
- Inamori Foundation
- Shibuya Science Culture and Sports Foundation
- Japan Society for the Promotion of Science (JP22K07812)
- Japan Society for the Promotion of Science (JP25K22607)
- Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering
- Mochida Memorial Foundation for Medical and Pharmaceutical Research
- Uehara Memorial Foundation
- Hokuriku bank
- Pharmaceutical Sciences Research Foundation
- Hokkoku Cancer Foundation
This publication has 42 references indexed in Scilit:
- Radiotheranostics with high-LET α-particle and auger Electron emitters: A coordination chemistry perspectiveCoordination Chemistry Reviews, 2026
- Can current preclinical strategies for radiopharmaceutical development meet the needs of targeted alpha therapy?European Journal of Nuclear Medicine and Molecular Imaging, 2024
- Recent advances in the development of 225Ac- and 211At-labeled radioligands for radiotheranosticsAnalytical Sciences, 2024
- Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approachesJournal of Controlled Release, 2022
- A comprehensive review on time-tested anticancer drug doxorubicinLife Sciences, 2021
- Detection of doxorubicin, cisplatin and therapeutic antibodies in formalin-fixed paraffin-embedded human cancer cellsHistochemistry and Cell Biology, 2020
- Synthesis of an amphiphilic tetrazine derivative and its application as a liposomal component to accelerate release of encapsulated drugsBioorganic & Medicinal Chemistry, 2019
- Radiotheranostics with radiolanthanides: Design, development strategies, and medical applicationsCoordination Chemistry Reviews, 2019
- Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electronsAdvanced Drug Delivery Reviews, 2017
- DNA-drug interactionsJournal of Molecular Biology, 1991